Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HiberGene Diagnostics Ltd.

www.hibergene.com

Latest From HiberGene Diagnostics Ltd.

HiberGene's Rapid Group B Strep Test Pregnant With Potential

A year after launching its first product, rapid molecular diagnostics specialist HiberGene now has a trio of infectious diseases tests under its belt. One of the tests, designed to detect Group B Streptococcus in pregnant women, is expected to be a major cash generator for the firm once it begins its sales ramp-up.

In Vitro Diagnostics Infectious Diseases

OUS Approvals Analysis: Slow Finish To 2016, But Still Ahead Of 2015

2016 finished with just two more non-US medical device approvals than 2015; December was by far the slowest month of the year for approvals from outside the US with just 11.

Approvals Europe

OUS Approvals Analysis: Edwards, Medtronic, Ra Medical Headline A Very Slow Month For Non-US Approvals

Medical devices approved outside the US in October include Medtronic's CoreValve Evolut R, Edwards' Acumen Hypotension Probability Indicator, and two approvals – for two completely different indications – for Ra Medical Systems' excimer laser technology.

Approvals Research & Development

Venture Funding Deals, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research, Analytical Equipment and Supplies sectors. This month’s column covers deals announced December 2015 through January 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • HiberGene Diagnostics Ltd.
  • Senior Management
  • Brendan K Farrell, Chmn. & CEO
    Peter Kidney, CFO
    Gary Keating, PhD, CTO
    Susanne Lalor, Dir., Mktg.
  • Contact Info
  • HiberGene Diagnostics Ltd.
    Phone: 905 3160
    Bracken Business Park, Unit 2
    Sandyford
    Dublin, 18
    Ireland
Advertisement
Advertisement
UsernamePublicRestriction

Register